On October 23, the State Drug Administration held a symposium on the supervision of traditional Chinese medicine in Beijing to thoroughly listen to the opinions and suggestions of academicians, Chinese medicine masters and senior experts in the field of traditional Chinese medicine to promote the reform of the traditional Chinese medicine review and approval system, strengthen the supervision of the entire chain of traditional Chinese medicine, and recent key tasks, and gather wisdom and strength to improve the traditional Chinese medicine inheritance, innovation and development mechanism. The conference believes that in recent years, the reform of the traditional Chinese medicine review and approval system has continued to deepen, promoting the continuous development of innovative vitality in traditional Chinese medicine. The conference said that the State Drug Administration will further increase policy support in the field of traditional Chinese medicine, optimize supervision models and evaluation methods, improve the system of guiding principles, consolidate and expand innovative research and development of traditional Chinese medicine, promote the transformation of famous recipes, traditional Chinese medicine formulations in medical institutions, etc. into new medicines, broaden natural drug research and development paths, and solidly promote the inheritance, innovation and development of traditional Chinese medicine.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.